Seth Klarman - Baupost Group
Holding/activity history for Orexigen Therapeutics Inc (OREXQ)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2018 Q1 | 2,226,839 | <0.01 | $0.21 | $465,000 | SEC | ||
| 2017 Q4 | 2,226,839 | 0.03 | $1.29 | $2,873,000 | SEC | ||
| 2017 Q3 | 2,226,839 | 0.06 | $2.12 | $4,721,000 | SEC | ||
| 2017 Q2 | 2,226,839 | 0.08 | $2.90 | $6,458,000 | SEC | ||
| 2017 Q1 | 2,226,839 | 0.09 | $3.44 | $7,660,000 | SEC | ||
| 2016 Q4 | 2,226,839 | 0.05 | $1.74 | $3,875,000 | SEC | ||
| 2016 Q3 | 2,226,839 | 0.11 | Buy | 0.11 | $3.32 | $7,393,000 | SEC |